Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
eBWVNyUbe8TcW2N0
